Home › Funds › WILKINS INVESTMENT COUNSEL INC › TECH

WILKINS INVESTMENT COUNSEL INC position in TECH

BIO-TECHNE CORP · Health Care

WILKINS INVESTMENT COUNSEL INC reported holding 188,267 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$13.6M, representing 1.79% of its reported portfolio and ranking #22 among its reported holdings. WILKINS INVESTMENT COUNSEL INC has disclosed TECH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)188.27K sh
Reported value held$13.64M
Portfolio Weight1.79%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WILKINS INVESTMENT COUNSEL INC's TECH position evolved

WILKINS INVESTMENT COUNSEL INC first disclosed a stake in TECH in Q3 2023 at 12,450 shares (US$847K). The position peaked in Q3 2026 at 188,267 shares, worth US$13.6M. Across 13 filings, WILKINS INVESTMENT COUNSEL INC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 188,267 shares valued at US$13.6M — a reduction of -1,145 shares quarter over quarter.. Notable position changes include a 40% increase in Q4 2024 (shares fell 19% over the following quarter), a 355% increase in Q2 2025 (shares rose 8% over the following quarter), a 69% increase in Q1 2026 (shares rose 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.45K $847.00K New
Q4 2023 14.84K $1.15M Add
Q1 2024 13.79K $970.68K Reduce
Q2 2024 16.49K $1.18M Add
Q3 2024 17.14K $1.37M Add
Q4 2024 23.99K $1.73M Add
Q1 2025 19.04K $1.12M Reduce
Q2 2025 86.61K $4.46M Add
Q3 2025 95.62K $5.32M Add
Q4 2025 103.27K $6.07M Add
Q1 2026 174.12K $9.10M Add
Q2 2026 189.41K $13.38M Add
Q3 2026 188.27K $13.64M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 27 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has WILKINS INVESTMENT COUNSEL INC held TECH?

WILKINS INVESTMENT COUNSEL INC has disclosed TECH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WILKINS INVESTMENT COUNSEL INC's current position in TECH?

As of Q3 2026, WILKINS INVESTMENT COUNSEL INC holds 188.27K shares of TECH (BIO-TECHNE CORP), valued at $13.64M, representing 1.79% of its reported portfolio and ranking #22.

Has WILKINS INVESTMENT COUNSEL INC been buying or selling TECH?

In the latest 13F filing (Q3 2026), WILKINS INVESTMENT COUNSEL INC reduced its position in TECH. The position peaked in Q3 2026 at 188.27K shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.